Retraction
Dapagliflozin Inhibits Ventricular Remodeling in Heart Failure Rats by Activating Autophagy through AMPK/mTOR Pathway
Paper Information
Record ID:
60494
Author(s):
Publication Date:
September 23, 2022
Retraction Date:
November 29, 2023
(2.0 year years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Hindawi
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (9)
9
Total Citations5
Post-Retraction(55.6%)
3
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
0
Within 30 days
5
Within 1 year
0
After 2+ years
282
Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Cardioprotection of Canagliflozin, Dapagliflozin, and Empagliflozin: lessons from preclinical studies
Rayla Rodrigues Soares, Larissa Freitas Viggiani, Juliano Moreira Reis Filho et al. (4 authors)
Chemico-Biological Interactions
Published: Sep 2024
282 days after retraction
Cardiovascular outcomes and molecular targets for the cardiac effects of Sodium-Glucose Cotransporter 2 Inhibitors: A systematic review
Rosalinda Madonna, Filippo Biondi, Mattia Alberti et al. (6 authors)
Biomedicine & Pharmacotherapy
Open Access
Published: Apr 2024
5 citations
5 citations
150 days after retraction
Compound Danshen Tablets ameliorate myocardial ischemia/reperfusion injury-induced ventricular remodeling by regulating autophagy via AMPK/mTOR signaling pathway
Qiaoyu Li, Yun Luo, Haibiao Guo et al. (8 authors)
Chinese Herbal Medicines
Open Access
Published: Apr 2024
124 days after retraction
Role and molecular mechanisms of SGLT2 inhibitors in pathological cardiac remodeling (Review)
Bixian Chen, Jing Guo, Ye Hongmei et al. (5 authors)
Molecular Medicine Reports
Open Access
Published: Mar 2024
10 citations
10 citations
103 days after retraction
Dapagliflozin alleviates high glucose‐induced injury of endothelial cells via inducing autophagy
Gen Li, Ningxin Hou, Huagang Liu et al. (7 authors)
Clinical and Experimental Pharmacology and Physiology
Published: Feb 2024
2 citations
2 citations
84 days after retraction
Current Role of SLGT2 Inhibitors in the Management of the Whole Spectrum of Heart Failure: Focus on Dapagliflozin
Carlos Escobar Cervantes, Domingo A. Pascual‐Figal, Luís Manzano et al. (5 authors)
Journal of Clinical Medicine
Open Access
Published: Oct 2023
5 citations
5 citations
33 days before retraction
Mechanisms of SGLT2 Inhibitors in the Treatment of Myocardial Ischemia-Reperfusion Injury in Animal Models
人榕 黎
Advances in Clinical Medicine
Published: Jan 2023
332 days before retraction
Retracted: Dapagliflozin Inhibits Ventricular Remodeling in Heart Failure Rats by Activating Autophagy through AMPK/mTOR Pathway
Computational and Mathematical Methods in Medicine
Computational and Mathematical Methods in Medicine
Open Access
Published: Jan 2023
332 days before retraction
Quick Stats
Total Citations:
16
Years Since Retraction:
2.0 year
Open Access:
Yes
Last Checked:
Jul 24, 2025